Average Co-Inventor Count = 3.78
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Elan Pharmaceuticals, Inc. (19 from 202 patents)
2. Activesite Pharmaceuticals, Inc. (9 from 9 patents)
3. Athena Neurosciences, Inc. (7 from 35 patents)
4. Eli Lilly and Company (5 from 4,446 patents)
5. Other (3 from 832,843 patents)
6. Rezolute, Inc. (3 from 8 patents)
7. Joslin Diabetes Center, Inc. (1 from 72 patents)
38 patents:
1. 12240818 - Crystalline forms of plasma kallikrein inhibitors
2. 11306061 - Crystalline forms of plasma kallikrein inhibitors
3. 11267790 - Processes for preparing plasma kallikrein inhibitors
4. 9206123 - Prodrugs of inhibitors of plasma kallikrein
5. 8691861 - Prodrugs of inhibitors of plasma kallikrein
6. 8658685 - Methods for treatment of kallikrein-related disorders
7. 8609866 - Prodrugs of inhibitors of plasma kallikrein
8. 8258170 - Inhibitors of plasma kallikrein
9. 7977380 - Inhibitors of plasma kallikrein
10. 7718413 - Glycosylation variants of BACE
11. 7625944 - Inhibitors of plasma kallikrein
12. 7608749 - Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation
13. 7514408 - β-secretase enzyme compositions and methods
14. 7482136 - Glycosylation variants of BACE
15. 7456007 - β-secretase enzyme compositions and methods